MedTrace Logo

Collection and Distribution of Biospecimens for Novel Research

NCT05080907 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2022-11-09

No results posted yet for this study

Summary

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").

Conditions

Interventions

OTHER

Observational

Subjects for observational study Various conditions \& healthy subjects

Sponsors & Collaborators

  • iSpecimen Inc

    lead INDUSTRY

Eligibility

Min Age
1 Year
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-15
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080907 on ClinicalTrials.gov